Salt Lake City, UT, Jan. 06, 2025 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announces that co-founder and CEO Chris Gibson, PhD will present at the upcoming 43rd Annual JP Morgan Healthcare Conference in San Francisco.
On Monday, January 13, 7:30am PT (10:30am ET), at the Westin St. Francis in the Elizabethan Room A/B, Dr. Gibson will present updates on Recursion’s latest clinical pipeline, partnerships, and platform following the company’s recent combination with Exscientia. The talk will be available on Recursion’s website for at least 30 days following the presentation here: https://ir.recursion.com/news-events/events-presentations.
CONTACT: Ryan Kelly Recursion Pharmaceuticals media@recursion.com
GlobeNewswire,is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Latest posts by GlobeNewswire (see all)
- WHEN LIGHT COMES UNEXPECTED: Clean Historical Fiction With Faith at the Center and Family at the Heart - July 3, 2025
- 2030 Vision: India’s Missile Market Poised for Growth, Innovation, Strategic Drivers & Global Reach 2030 - July 3, 2025
- Special Needs Network Condemns Deep Federal Cuts to Medicaid, Food Assistance - July 3, 2025
